Document Detail

Long-term therapy of coronary artery disease: a vascular biology perspective.
MedLine Citation:
PMID:  11191116     Owner:  NLM     Status:  MEDLINE    
When evaluating a patient with known coronary artery disease or a patient with hypercholesterolemia without overt clinical symptoms of coronary artery disease or other vascular disease, it is helpful to understand the vascular biology behind primary and secondary prevention. This article reviews the progression of the atherosclerotic plaque, endothelial function, and the impact of current modes of therapy.
A J Mathé; M B Clearfield
Related Documents :
9351736 - Dobutamine stress echocardiography in the detection of coronary artery disease: importa...
10455096 - Restrictive pericarditis.
9230166 - Activated factor vii levels in patients with angiographically confirmed coronary artery...
9555776 - High anti-cytomegalovirus (cmv) igg antibody titer is associated with coronary artery d...
22341576 - Presentation and management of carotid artery aneurysms and pseudoaneurysms.
23128536 - Orbital cellulitis complicated by central retinal artery occlusion.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Journal of the American Osteopathic Association     Volume:  100     ISSN:  0098-6151     ISO Abbreviation:  J Am Osteopath Assoc     Publication Date:  2000 Nov 
Date Detail:
Created Date:  2001-01-17     Completed Date:  2001-02-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7503065     Medline TA:  J Am Osteopath Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S13-6     Citation Subset:  IM    
Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth/Texas College of Osteopathic Medicine, 3500 Camp Bowie Blvd, Fort Worth, TX 76107-2644, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticholesteremic Agents / therapeutic use
Coronary Artery Disease / drug therapy
Coronary Disease / drug therapy*
Disease Progression
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hypercholesterolemia / drug therapy
Platelet Aggregation Inhibitors / therapeutic use
Risk Factors
Time Factors
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The clinical spectrum of acute coronary syndromes.
Next Document:  The venous side: current directions in anticoagulant therapy.